Chemotactic effect of prorenin on human aortic smooth muscle cells: A novel function of the (pro)renin receptor

Cardiovascular Research

Volumn 95, Issue 3, 2012, Pages 366-374

  Greco, Carolina M ^a   Camera, Marina ^a,b   Facchinetti, Laura ^b   Brambilla, Marta ^b   Pellegrino, Sara ^a   Gelmi, Maria Luisa ^a   Tremoli, Elena ^a,b   Corsini, Alberto ^a   Ferri, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Cell migration; Focal adhesion kinase; Rac1; RhoA; Smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALLOPURINOL; FOCAL ADHESION KINASE 1; GUANOSINE TRIPHOSPHATE; PRORENIN; PRORENIN RECEPTOR; RAC1 PROTEIN; SMALL INTERFERING RNA; CALPAIN; CELL SURFACE RECEPTOR; CYSTEINE PROTEINASE INHIBITOR; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; PTK2 PROTEIN, HUMAN; RAC1 PROTEIN, HUMAN; RENIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, HUMAN;

AORTA; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; FOCAL ADHESION; HUMAN; HUMAN CELL; IN VITRO STUDY; MAMMARY ARTERY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; CELL CULTURE; CHEMOTAXIS; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME; VASCULAR SMOOTH MUSCLE; VIDEO MICROSCOPY;

AORTA; CALPAIN; CELLS, CULTURED; CHEMOTAXIS; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETON; FOCAL ADHESION KINASE 1; FOCAL ADHESIONS; HUMANS; MICROSCOPY, VIDEO; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RAC1 GTP-BINDING PROTEIN; RECEPTORS, CELL SURFACE; RENIN; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84871707900     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs204     Document Type: Article

References (43)

1. Sealey JE, Atlas SA, Laragh JH. Prorenin and other large molecular weight forms of renin. Endocr Rev 1980;1:365-391.
2. Nabi AH, Kageshima A, Uddin MN, Nakagawa T, Park EY, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med 2006;18:483-488.
3. Batenburg WW, Krop M, Garrelds IM, de Vries R, de Bruin RJ, Burckle CA et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens 2007;25:2441-2453. (Pubitemid 350060383)
4. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002;109:1417-1427. (Pubitemid 34596167)
5. Methot D, Silversides DW, Reudelhuber TL. In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res 1999;84:1067-1072. (Pubitemid 29227686)
6. Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996;50:1897-1903. (Pubitemid 26417532)
7. Burckle CA, Jan Danser AH, Muller DN, Garrelds IM, Gasc JM, Popova E et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006;47:552-556. (Pubitemid 43843874)
8. Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, Uddin MN et al. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 2007;18:1789-1795. (Pubitemid 46870315)
9. Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 2008;51: 682-688. (Pubitemid 351301521)
10. Abassi Z, Winaver J, Feuerstein GZ. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality. Biochem Pharmacol 2009;78:933-940.
11. Feldman DL, Jin L, Xuan H, Contrepas A, Zhou Y, Webb RL et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension 2008;52:130-136.
12. Ferri N, Greco CM, Maiocchi G, Corsini A. Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells. J Renin Angiotensin Aldosterone Syst 2011;12:469-474.
13. Ballerio R, Brambilla M, Colnago D, Parolari A, Agrifoglio M, Camera M et al. Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits. J Thromb Haemost 2007;5:174-180. (Pubitemid 44921083)
14. Corsini A, Bonfatti M, Quarato P, Accomazzo MR, Raiteri M, Sartani A et al. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes. J Cardiovasc Pharmacol 1996;28:687-694. (Pubitemid 26397028)
15. White DP, Caswell PT, Norman JC. avb3 and a5b1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration. J Cell Biol 2007;177:515-525. (Pubitemid 46718279)
16. Palamidessi A, Frittoli E, Garre M, Faretta M, Mione M, Testa I et al. Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration. Cell 2008; 134:135-147. (Pubitemid 351905741)
17. Ferri N, Corsini A, Bottino P, Clerici F, Contini A. Virtual screening approach for the identification of new Rac1 inhibitors. J Med Chem 2009;52:4087-4090.
18. Ferri N, Colombo G, Ferrandi C, Raines EW, Levkau B, Corsini A. Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol 2007;27:1043-1049. (Pubitemid 46641955)
19. Clavreul N, Sansilvestri-Morel P, Magard D, Verbeuren TJ, Rupin A. (Pro)renin promotes fibrosis gene expression in HEK cells through a Nox4-dependent mechanism. Am J Physiol Renal Physiol 2011;300:F1310-F1318.
20. 2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response. J Physiol 2009;587:2537-2553.
21. Carragher NO, Fincham VJ, Riley D, Frame MC. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J Biol Chem 2001;276:4270-4275.
22. Huttenlocher A, Palecek SP, Lu Q, Zhang W, Mellgren RL, Lauffenburger DA et al. Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 1997;272:32719-32722. (Pubitemid 28023599)
23. Figueiredo-Pereira ME, Banik N, Wilk S. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J Neurochem 1994;62:1989-1994. (Pubitemid 24121895)
24. Uraoka M, Ikeda K, Nakagawa Y, Koide M, Akakabe Y, Nakano-Kurimoto R et al. Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system. Biochem Biophys Res Commun 2009;390: 1202-1207.
25. Saris JJ, 't Hoen PA, Garrelds IM, Dekkers DH, den Dunnen JT, Lamers JM et al. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension 2006;48:564-571. (Pubitemid 44843857)
26. Salinthone S, Tyagi M, Gerthoffer WT. Small heat shock proteins in smooth muscle. Pharmacol Ther 2008;119:44-54.
27. Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M. Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay. J Clin Invest 1989;83: 679-687. (Pubitemid 19061192)
28. Yokota H, Mori F, Kai K, Nagaoka T, Izumi N, Takahashi A et al. Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay. Br J Ophthalmol 2005;89: 871-873. (Pubitemid 40904812)
29. Batenburg WW, Danser AJ. Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren. J Renin Angiotensin Aldosterone Syst 2008;9: 181-184.
30. Batenburg WW, de Bruin RJ, van Gool JM, Müller DN, Bader M, Nguyen G et al. Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2008;28:1151-1157.
31. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996;94: 2756-2767. (Pubitemid 26411739)
32. 1A receptor. Circulation 2004;110:3849-3857. (Pubitemid 40023984)
33. Ohishi M, Ueda M, Rakugi H, Naruko T, Kojima A, Okamura A et al. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. J Hypertens 1997;15:1295-1302. (Pubitemid 27453182)
34. Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD. Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation 1998;98:800-807. (Pubitemid 28391846)
35. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 2004;114:1128-1135. (Pubitemid 39578702)
36. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A et al. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006;17:2495-2503. (Pubitemid 44300965)
37. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006;47:894-900. (Pubitemid 44297561)
38. Susic D, Zhou X, Frohlich ED, Lippton H, Knight M. Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet. Am J Physiol Heart Circ Physiol 2008;295:H1117-H1121.
39. Shan Z, Cuadra AE, Sumners C, Raizada MK. Characterization of a functional (pro)-renin receptor in rat brain neurons. Exp Physiol 2008;93:701-708. (Pubitemid 351595061)
40. He M, Zhang L, Shao Y, Wang X, Huang Y, Yao T et al. Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur J Pharmacol 2009;606:155-161.
41. Schlaepfer DD, Mitra SK, Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 2004;1692:77-102. (Pubitemid 38898737)
42. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006;18:516-523. (Pubitemid 44332916)
43. Chan KT, Bennin DA, Huttenlocher A. Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J Biol Chem 2010;285: 11418-11426.